A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene
- 23 March 2007
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 156 (5) , 1063-1065
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Increased Activity of Coagulation Factor XII (Hageman Factor) Causes Hereditary Angioedema Type IIIThe American Journal of Human Genetics, 2006
- The K+ channel iKCA1 potentiates Ca2+ influx and degranulation in human lung mast cellsJournal of Allergy and Clinical Immunology, 2004
- Angioedema and Oral ContraceptionDermatology, 2003
- Hereditary angioedema type III: An additional French pedigree with autosomal dominant transmissionJournal of Allergy and Clinical Immunology, 2001
- Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedemaJournal of Allergy and Clinical Immunology, 2000
- Hereditary angioedema with normal C1-inhibitor activity in womenThe Lancet, 2000
- Molecular basis of estrogen regulation of Hageman factor XII gene expressionEndocrinology, 1995
- A sensitive method to assay blood complement C Inhibitor activityClinica Chimica Acta, 1988